CA2722996A1 - Analogues peptidiques du gluten non inflammatoires utilises comme biomarqueurs de la maladie coeliaque - Google Patents
Analogues peptidiques du gluten non inflammatoires utilises comme biomarqueurs de la maladie coeliaque Download PDFInfo
- Publication number
- CA2722996A1 CA2722996A1 CA2722996A CA2722996A CA2722996A1 CA 2722996 A1 CA2722996 A1 CA 2722996A1 CA 2722996 A CA2722996 A CA 2722996A CA 2722996 A CA2722996 A CA 2722996A CA 2722996 A1 CA2722996 A1 CA 2722996A1
- Authority
- CA
- Canada
- Prior art keywords
- peptide
- gluten
- mer
- seq
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5394908P | 2008-05-16 | 2008-05-16 | |
US61/053,949 | 2008-05-16 | ||
PCT/US2009/002997 WO2009139887A2 (fr) | 2008-05-16 | 2009-05-13 | Analogues peptidiques du gluten non inflammatoires utilisés comme biomarqueurs de la maladie coeliaque |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2722996A1 true CA2722996A1 (fr) | 2009-11-19 |
Family
ID=41319214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2722996A Abandoned CA2722996A1 (fr) | 2008-05-16 | 2009-05-13 | Analogues peptidiques du gluten non inflammatoires utilises comme biomarqueurs de la maladie coeliaque |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2277046A2 (fr) |
AU (1) | AU2009246925A1 (fr) |
CA (1) | CA2722996A1 (fr) |
WO (1) | WO2009139887A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2367561B1 (fr) | 2008-11-30 | 2015-05-20 | Immusant, Inc. | Compositions et procédés pour le traitement d'une maladie coeliaque |
EP2673292A4 (fr) * | 2011-02-08 | 2014-05-21 | Phadia Ab | Antigènes de blé et peptides pour le diagnostic de l'hypersensibilité induite par le blé |
US20160041148A1 (en) * | 2013-03-14 | 2016-02-11 | Immusant,Inc. | Placebo-controlled gluten challenge method |
CA2923822A1 (fr) | 2013-09-10 | 2015-03-19 | Immusant, Inc. | Dosage d'une composition peptidique de gluten |
ES2556177B1 (es) * | 2014-07-09 | 2016-10-20 | Universidad De Sevilla | Detección de péptidos del gluten en fluidos humanos |
AU2015323979A1 (en) | 2014-09-29 | 2017-05-18 | Immusant, Inc. | Use of HLA genetic status to assess or select treatment of celiac disease |
JP6738888B2 (ja) * | 2016-02-23 | 2020-08-12 | 田中貴金属工業株式会社 | グリアジン検出用免疫クロマト分析装置、免疫クロマト分析キットおよび免疫クロマト分析方法 |
WO2018005688A1 (fr) * | 2016-06-28 | 2018-01-04 | Immusant, Inc. | Compositions et procédés de diagnostic de la maladie coeliaque à l'aide de cytokines/chimiokines circulantes |
WO2019147990A1 (fr) * | 2018-01-26 | 2019-08-01 | The Regents Of The University Of California | Méthodes et compositions concernant la perméabilité intestinale |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7202216B2 (en) * | 2002-05-14 | 2007-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for celiac sprue |
US7462688B2 (en) * | 2002-05-14 | 2008-12-09 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for diagnostic and therapeutic methods for celiac sprue |
US7534426B2 (en) * | 2004-04-26 | 2009-05-19 | The Board Of Trustees Of The Leland Stanford Junior University | Glutenase enzyme assays |
WO2008052185A2 (fr) * | 2006-10-26 | 2008-05-02 | Alba Therapeutics Corp | Matériaux et procédés pour le traitement de la maladie cœliaque |
-
2009
- 2009-05-13 WO PCT/US2009/002997 patent/WO2009139887A2/fr active Application Filing
- 2009-05-13 EP EP09746974A patent/EP2277046A2/fr not_active Withdrawn
- 2009-05-13 CA CA2722996A patent/CA2722996A1/fr not_active Abandoned
- 2009-05-13 AU AU2009246925A patent/AU2009246925A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2277046A2 (fr) | 2011-01-26 |
AU2009246925A1 (en) | 2009-11-19 |
WO2009139887A3 (fr) | 2010-02-04 |
WO2009139887A2 (fr) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2722996A1 (fr) | Analogues peptidiques du gluten non inflammatoires utilises comme biomarqueurs de la maladie coeliaque | |
Pulido et al. | Introduction of oats in the diet of individuals with celiac disease: a systematic review | |
Busby et al. | Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation | |
US7462688B2 (en) | Peptides for diagnostic and therapeutic methods for celiac sprue | |
Liddle et al. | Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol | |
Pruimboom et al. | The opioid effects of gluten exorphins: asymptomatic celiac disease | |
Gass et al. | Effect of barley endoprotease EP-B2 on gluten digestion in the intact rat | |
Hill et al. | Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease | |
JP2013129672A (ja) | 代謝障害の診断及び治療方法 | |
EA037603B1 (ru) | Композиции и способы для лечения целиакии спру | |
AU2015249383A1 (en) | Compositions comprising gluten peptides and uses thereof | |
Di Stasio et al. | Comparative analysis of in vitro digestibility and immunogenicity of gliadin proteins from durum and einkorn wheat | |
US20160041148A1 (en) | Placebo-controlled gluten challenge method | |
Tye-Din et al. | Immunopathogenesis of celiac disease | |
Zhu et al. | How does a celiac iceberg really float? The relationship between celiac disease and gluten | |
WO1980001415A1 (fr) | Essai de la fonction exocrine du pancreas | |
US20110065758A1 (en) | Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions | |
DK2203188T3 (en) | Biomarker for measuring the efficacy of drugs in enteropathic disease | |
WO2011000773A1 (fr) | Test d'efficacité dans le traitement de la maladie cœliaque | |
JP2008533013A (ja) | 空腹時の血漿コレシストキニン濃度を高めるのに活性を示すポテトプロテナーゼ阻害剤ii | |
D'Alessio et al. | Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men | |
Baldassarre et al. | Celiac disease: pathogenesis and novel therapeutic strategies | |
US8569448B2 (en) | NMDAR biomarkers for diagnosis and treatment of traumatic brain injury and other disorders | |
RU2690665C2 (ru) | Обнаружение глютеновых пептидов в жидкостях организма человека | |
US20130065255A1 (en) | Biomarker to Measure Drug Efficacy in Enteropathic Disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |